In adults with T2D, obesity, and HbA1c > 9%, without severe signs or symptoms of hyperglycemia, a combination of basal insulin and GLP-1 RA therapy SHOULD BE CONSIDERED to improve glycemic control. The gene discussed is GCG; the disease is type 2 diabetes mellitus.